[1]曹进明.噻托溴铵与异丙托溴铵治疗慢阻肺的效果及对患者血清炎症因子的影响[J].医学信息,2022,35(21):131-133.[doi:10.3969/j.issn.1006-1959.2022.21.034]
　CAO Jin-ming.Effect of Tiotropium Bromide and Ipratropium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease and its Effect on Serum Inflammatory Factors[J].Journal of Medical Information,2022,35(21):131-133.[doi:10.3969/j.issn.1006-1959.2022.21.034]
点击复制

噻托溴铵与异丙托溴铵治疗慢阻肺的效果及对患者血清炎症因子的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年21期
页码:
131-133
栏目:
药物与临床
出版日期:
2022-11-01

文章信息/Info

Title:
Effect of Tiotropium Bromide and Ipratropium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease and its Effect on Serum Inflammatory Factors
文章编号:
1006-1959（2022）21-0131-03
作者:
曹进明
（铅山县人民医院呼吸内科，江西 铅山 334599）
Author(s):
CAO Jin-ming
(Department of Respiratory Medicine,Yanshan County People’s Hospital,Yanshan 334599,Jiangxi,China)
关键词:
噻托溴铵; 异丙托溴铵; 慢阻肺; 炎症因子
Keywords:
Tiotropium bromide;  Ipratropium Bromide; Chronic obstructive pulmonary disease; Inflammatory factors
分类号:
R562.25
DOI:
10.3969/j.issn.1006-1959.2022.21.034
文献标志码:
A
摘要:
目的 研究噻托溴铵与异丙托溴铵治疗慢阻肺的效果及对血清炎症因子的影响。方法 选取2020年1月-2021年1月在我院诊治的62例慢阻肺患者为研究对象，采用随机数字表法分为对照组和观察组，各31例。对照组采用异丙托溴铵治疗，观察组采用噻托溴铵治疗，比较两组临床疗效、慢阻肺自我评估测试（CAT）评分、血清炎症因子水平、肺功能指标及不良反应发生率。结果 观察组治疗总有效率为93.55%，高于对照组的80.65%（P＜0.05）；两组CAT评分均低于治疗前，且观察组低于对照组（P＜0.05）；两组降钙素原（PCT）、C反应蛋白（CRP）、白细胞（WBC）水平低于治疗前，且观察组低于对照组（P＜0.05）；两组用力肺活量（FVC）、第1秒用力呼气容积占预计值百分比（FEV1%）大于治疗前，且观察组大于对照组（P＜0.05）；两组不良反应发生率比较，差异无统计学意义（P＞0.05）。结论 噻托溴铵与异丙托溴铵治疗慢阻肺均具有一定的效果，但噻托溴铵的疗效更好，可改善患者肺功能，降低血清炎症因子水平、CAT评分，值得临床应用。
Abstract:
Objective To study the effect of tiotropium bromide and ipratropium bromide in the treatment of chronic obstructive pulmonary disease and its effect on serum inflammatory factors.Methods A total of 62 patients with chronic obstructive pulmonary disease diagnosed and treated in our hospital from January 2020 to January 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, with 31 cases in each group. The control group was treated with ipratropium bromide, and the observation group was treated with tiotropium bromide. The clinical efficacy, COPD self-assessment test (CAT) score, serum inflammatory factor level, lung function index and incidence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 93.55%, which was higher than 80.65% of the control group (P<0.05). The CAT scores of the two groups were lower than those before treatment, and the observation group was lower than the control group (P<0.05). The levels of procalcitonin (PCT), C-reactive protein (CRP) and white blood cell (WBC) in the two groups were lower than those before treatment, and those in the observation group were lower than the control group (P<0.05). The forced vital capacity (FVC) and the percentage of forced expiratory volume in the first second (FEV1%) in the two groups were higher than those before treatment, and the observation group was higher than the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion Tiotropium bromide and ipratropium bromide in the treatment of chronic obstructive pulmonary disease have a certain effect, but tiotropium bromide is better, which can improve lung function, reduce serum levels of inflammatory factors, CAT score, and is worthy of clinical application.

参考文献/References:

[1]许迎辉,李响,韩玉英.噻托溴铵联合沙美特罗/丙酸氟替卡松吸入治疗对慢性阻塞性肺疾病患者肺功能的影响[J].中国医药导报,2016,13(3):146-149.[2]康莹,刘锦铭.胸腺肽α－1联合布地奈德混悬液雾化吸入对哮喘－慢阻肺重叠综合征患者的影响[J].实用心脑肺血管病杂志,2017,25(9):160-162．[3]李学玲,马政权.吸入糖皮质激素联合化痰降气活血汤对哮喘-慢阻肺重叠综合征患者病情、诱导痰细胞分类及内皮细胞功能的影响[J].现代中西医结合杂志,2018,27(24):105-108．[4]胡海涛,曾丽娟,屈磊,等.噻托溴铵联合吸入糖皮质激素对哮喘-慢阻肺重叠综合征患者肺功能、FeNO及免疫功能的影响[J].空军医学杂志,2017,33(2):113-117.[5]李汉高,李芳萍,刘美娟,等.吸入用复方异丙托溴铵溶液对慢性阻塞性肺疾病急性加重期老年患者血浆脑钠肽浓度的影响[J].中国临床药学杂志,2016,24(6):346-350.[6]黄怀焕,林坚耿,伍胜孟,等.慢阻肺急性加重期患者预后的影响因素分析[J].临床肺科杂志,2016,21(1):104-107.[7]施伟林,陈茜.灯盏花素联合补气祛瘀中药治疗 AECOPD 疗效及对免疫球蛋白、氧化应激指标的影响 [J].中国中医急症,2017,26(5):929-931.[8]刘苔,李娅,杜卫祺,等.不同雾化方法吸入布地奈德对慢性阻塞性肺疾病急性加重期患者胸肺顺应性及动脉血气指标的影响[J].中国现代医学杂志,2017,27(15):115-118.[9]王莹莹,郝兴亮,冯涛,等.痰嗜酸性粒细胞评估糖皮质激素治疗 AECOPD的疗效价值[J].临床药物治疗杂志,2017,15(7):22-25.[10]王沁,宋德胤.布地奈德联合沙丁胺醇雾化吸入治疗AECOPD 的疗效及对肺功能相关指标的影响[J].实用临床医药杂志,2016,20(7):38-40,44.[11]关瑞宁.痰热清注射液不同给药途径治疗AECOPD疗效对比分析[J].中国中医急症,2016,25(7):1435-1436. [12]孙虎,左蕾,叶远征,等.全身应用糖皮质激素对慢性阻塞 性肺疾病急性加重患者治疗效果的系统评价[J].中国呼吸与危重监护杂志,2017,16(1):1-8. [13]吴清松,饶平.不同剂量布地奈德联合异丙托溴铵对AECOPD患者主观症状、肺功能及动脉血气指标的影响[J].中国药房,2016,27(20):2816-2819.[14]顾红艳,马珺,葛娟,等.复方异丙托溴铵雾化吸入联合噻托溴铵干粉吸入序贯治疗慢性阻塞性肺疾病急性加重期患者的效果[J].实用临床医药杂志,2017,21(17):183-184.[15]赵稼萤,张瑞,黄雪元,等.中药喘可治注射液联合糖皮质激素与支气管舒张剂雾化吸入对AECOPD 患者炎症因子及免疫功能的影响[J].上海中医药大学学报,2016,30(3):22-26.[16]吴刚.糖皮质激素不同给药方式对 AECOPD 患者炎症因子及肺功能的影响[J].临床肺科杂志,2016,21(11):2018-2020.[17]刘领,杨霁,吴文杰,等.糖皮质激素对慢阻肺急性加重期患者凝血功能影响的观察[J].人民军医,2016,59(5):477-479.[18]孙丽娟,李珠.噻托溴铵联合无创呼吸机治疗慢阻肺并慢性呼吸衰竭的效果观察及对肺功能、T细胞免疫功能的影响[J].临床误诊误治,2020,33(10):31-35.[19]崔丽平,陈希胜,李旭.布地奈德粉吸入剂联合噻托溴铵粉雾剂治疗哮喘 - 慢阻肺重叠综合征的临床疗效[J].实用心脑肺血管病杂志,2017,25(3):100-103.

相似文献/References:

[1]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
　CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(21):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[2]周 佳,柴明思.布地奈德、异丙托溴铵气雾剂联合雾化吸入治疗对肺气肿患者肺功能及血液相关指标的影响[J].医学信息,2019,32(09):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
　ZHOU Jia,CHAI Ming-si.Effects of Budesonide and Ipratropium Bromide Aerosol Combined with Nebulized Inhalation on Pulmonary Function and Blood Related Indexes in Patients with Emphysema[J].Journal of Medical Information,2019,32(21):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
[3]刘江海.异丙托溴铵雾化吸入治疗慢阻肺急性加重期的临床疗效[J].医学信息,2019,32(20):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
　LIU Jiang-hai.Clinical Efficacy of Ipratropium Bromide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(21):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
[4]张 斌,刘宿慧,余长寿.孟鲁司特联合噻托溴铵对COPD患者血清细胞因子、血液流变学及肺功能的影响[J].医学信息,2020,33(02):144.[doi:10.3969/j.issn.1006-1959.2020.02.043]
　ZHANG Bin,LIU Su-hui,YU Chang-shou.Effect of Montelukast Combined with Tiotropium Bromide on Serum Cytokines,Hemorheology and Lung Function in Patients with COPD[J].Journal of Medical Information,2020,33(21):144.[doi:10.3969/j.issn.1006-1959.2020.02.043]
[5]陈小军.布地奈德联合噻托溴铵治疗哮喘-慢阻肺重叠综合征的疗效[J].医学信息,2020,33(06):154.[doi:10.3969/j.issn.1006-1959.2020.06.051]
　CHEN Xiao-jun.Efficacy of Budesonide Combined with Tiotropium Bromide in the Treatment of Asthma-COPD Overlap Syndrome[J].Journal of Medical Information,2020,33(21):154.[doi:10.3969/j.issn.1006-1959.2020.06.051]
[6]张志萍.噻托溴铵结合福莫特罗粉吸入剂对慢阻肺患者肺功能指标的影响[J].医学信息,2021,34(23):102.[doi:10.3969/j.issn.1006-1959.2021.23.029]
　ZHANG Zhi-ping.Effect of Tiotropium Combined with Formoterol Powder Inhalation on Pulmonary Function Indexes in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2021,34(21):102.[doi:10.3969/j.issn.1006-1959.2021.23.029]
[7]张广平.孟鲁司特钠治疗病毒性小儿哮喘的临床疗效及安全性[J].医学信息,2021,34(23):105.[doi:10.3969/j.issn.1006-1959.2021.23.030]
　ZHANG Guang-ping.Clinical Efficacy and Safety of Montelukast Sodium in the Treatment of Viral Asthma in Children[J].Journal of Medical Information,2021,34(21):105.[doi:10.3969/j.issn.1006-1959.2021.23.030]
[8]骈晓亮.吸入用激素联合噻托溴铵治疗慢性阻塞性肺疾病的临床疗效[J].医学信息,2022,35(05):105.[doi:10.3969/j.issn.1006-1959.2022.05.026]
　PIAN Xiao-liang.Clinical Effect of Inhaled Hormone Combined with Tiotropium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(21):105.[doi:10.3969/j.issn.1006-1959.2022.05.026]
[9]王 雪,章 晔,李宝华.孟鲁斯特钠片与异丙托溴铵和布地奈德混悬液雾化吸入对小儿呼吸道感染性咳嗽的临床疗效[J].医学信息,2022,35(12):190.[doi:10.3969/j.issn.1006-1959.2022.12.049]
　WANG Xue,ZHANG Ye,LI Bao-hua.Clinical Effect of Montelukast Sodium Tablets Combined with Ipratropine Bromide and Budesonide Mixed Suspension Atomization Inhalation on Children with Respiratory Tract Infection Cough[J].Journal of Medical Information,2022,35(21):190.[doi:10.3969/j.issn.1006-1959.2022.12.049]
[10]孙 茜.布地奈德福莫特罗联合噻托溴铵吸入剂治疗慢性阻塞性肺疾病的疗效[J].医学信息,2022,35(20):60.[doi:10.3969/j.issn.1006-1959.2022.20.014]
　SUN Qian.Efficacy of Budesonide Formoterol Combined with Tiotropium Bromide Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(21):60.[doi:10.3969/j.issn.1006-1959.2022.20.014]

更新日期/Last Update: 1900-01-01